For citations:
Tsaur G.A., Druy A.Е., Solodonikov A.G., Popov A.M., Shapochnik A.P., Vakhonina L.V., Vlasova A.A., Arakaev О.R., Riger T.O., Verzhbitskaya T.Yu., Olshanskaya Yu.V., Shorikov E.V., Tsvirenko A.V., Saveliev L.I., Fechina L.G. Application of cytogenetic risk factors and molecular markers, assessed by multiplex ligation-dependent probe amplification for prognosis of outcome in pediatric B-cell precursor acute lymphoblastic leukemia do not bring any advantage over detection of isolated IKZF1 deletion. Russian Journal of Pediatric Hematology and Oncology. 2018;5(1):34-43. (In Russ.) https://doi.org/10.17650/2311-1267-2018-5-1-34-43
Email this article 